On the TA front, VIT back to re-test support - break this and low 20s incoming.The FA conundrum is that FY23 results will look good but is it deceiving?When your established competitors (EBO, API, SIG) are operating at 10% Gross Margin to VITs >30% then they're going to come for your lunch.At an annualised cost base of $20m (VIT had $10m below the line expenses for HY) it means $100m revenue is actually loss-making at 10% GM.GM at 10% requires revenue of $200m to B/E.So is it a value trap?
- Forums
- ASX - By Stock
- VIT
- Ann: Vitura Health joining S&P/ASX All Ordinaries Index
Ann: Vitura Health joining S&P/ASX All Ordinaries Index, page-92
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VIT (ASX) to my watchlist
|
|||||
Last
9.1¢ |
Change
0.011(13.8%) |
Mkt cap ! $52.40M |
Open | High | Low | Value | Volume |
8.0¢ | 9.3¢ | 8.0¢ | $71.94K | 816.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 16109 | 8.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.2¢ | 2600 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 32203 | 0.093 |
2 | 21984 | 0.088 |
1 | 782 | 0.080 |
1 | 10500 | 0.078 |
1 | 17800 | 0.073 |
Price($) | Vol. | No. |
---|---|---|
0.091 | 1642 | 1 |
0.092 | 2600 | 1 |
0.093 | 9137 | 1 |
0.095 | 15277 | 2 |
0.097 | 40528 | 2 |
Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
Featured News
VIT (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online